[Captopril and hypertensive crisis]. 1988

F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations

Related Publications

F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
September 1985, Lancet (London, England),
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
June 1983, Arquivos brasileiros de cardiologia,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
July 1985, Lancet (London, England),
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
November 1981, Arquivos brasileiros de cardiologia,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
December 1983, Schweizerische medizinische Wochenschrift,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
January 1983, European journal of clinical pharmacology,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
February 1989, Clinical pharmacy,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
January 2016, The Journal of emergency medicine,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
January 1987, Revista clinica espanola,
F Marcos Sánchez, and P Parrilla Herranz, and A Portillo Cazorla, and M I Gámez Cabero
June 1987, Medicina clinica,
Copied contents to your clipboard!